# Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation

> clinical trial · VERIFIED · 2026-07-08

Status: NOT_YET_RECRUITING · Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd. · Condition: Pancreatic Cancer

- Company: Jiangxi Kvvit Pharmaceutical Co., Ltd.
- Sector: Pancreatic Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07689539

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.